Neptune Technologies & Bioresources Inc Quick Ratio 2009-2018 | NEPT

Historical quick ratio values for Neptune Technologies & Bioresources Inc (NEPT) over the last 10 years.
Neptune Technologies & Bioresources Inc Quick Ratio Historical Data
Date Current Assets - Inventory Current Liabilities Quick Ratio
2018-12-31 $0.02B $0.01B 1.72
2018-09-30 $0.02B $0.01B 2.00
2018-06-30 $0.02B $0.01B 2.08
2016-11-30 $0.02B $0.01B 1.32
2016-08-31 $0.02B $0.01B 1.34
2016-05-31 $0.02B $0.01B 1.52
2016-03-31 $0.02B $0.01B 1.36
2016-02-29 $0.00B $0.00B 0.00
2015-12-31 $0.02B $0.01B 2.40
2015-09-30 $0.02B $0.01B 2.89
2015-06-30 $0.02B $0.01B 2.93
2015-03-31 $0.03B $0.01B 3.90
2014-12-31 $0.04B $0.01B 3.93
2014-09-30 $0.05B $0.01B 3.54
2014-06-30 $0.06B $0.02B 3.98
2014-03-31 $0.05B $0.02B 3.16
2013-12-31 $0.02B $0.01B 1.65
2013-09-30 $0.03B $0.01B 2.81
2013-06-30 $0.03B $0.01B 3.34
2013-03-31 $0.04B $0.01B 4.37
2013-02-28 $0.00B $0.00B 0.00
2012-12-31 $0.05B $0.02B 3.32
2012-09-30 $0.02B $0.01B 1.73
2012-06-30 $0.02B $0.01B 2.11
2012-03-31 $0.03B $0.01B 2.89
2011-12-31 $0.02B $0.01B 4.61
2011-09-30 $0.02B $0.01B 3.67
2011-06-30 $0.02B $0.01B 3.48
2011-03-31 $0.01B $0.01B 1.88
2010-12-31 $0.01B $0.00B 2.82
2010-09-30 $0.01B $0.00B 1.56
2010-06-30 $0.01B $0.01B 1.51
2010-03-31 $0.01B $0.00B 1.43
2009-12-31 $0.01B $0.00B 1.50
2009-09-30 $0.01B $0.00B 1.50
2009-06-30 $0.01B $0.00B 2.20
2009-03-31 $0.01B $0.00B 2.55
2008-12-31 $0.00B $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.266B $0.022B
Neptune Wellness Solutions Inc. operates as a nutrition supplement company. It develops and produces cannabis products, marine oils, seed oils and pet supplements. Neptune Wellness Solutions Inc., formerly known as Neptune Technologies & Bioressources Inc., is headquartered in Laval, Canada.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $138.463B 27.37
Medtronic (MDT) Ireland $123.238B 18.02
Stryker (SYK) United States $72.140B 26.48
Boston Scientific (BSX) United States $52.625B 25.66
Baxter (BAX) United States $39.440B 25.23
Zimmer Biomet Holdings (ZBH) United States $25.620B 16.40
Smith & Nephew SNATS (SNN) United Kingdom $17.350B 0.00
Canopy Growth (CGC) Canada $15.290B 0.00
ResMed (RMD) United States $13.957B 26.47
Aurora Cannabis (ACB) Canada $10.062B 71.00
Bio-Rad Laboratories (BIO) United States $9.398B 53.62
Hill-Rom Holdings (HRC) United States $6.885B 21.30
Perrigo (PRGO) Ireland $6.613B 10.72
Insulet (PODD) United States $5.778B 1949.40
GW Pharmaceuticals (GWPH) United Kingdom $5.086B 0.00
ICU Medical (ICUI) United States $4.899B 30.50
Haemonetics (HAE) United States $4.340B 38.50
Hutchison China MediTech (HCM) China $3.826B 0.00
Agios Pharmaceuticals (AGIO) United States $3.786B 0.00
Neogen (NEOG) United States $3.284B 50.45
NuVasive (NUVA) United States $2.842B 24.79
Quidel (QDEL) United States $2.668B 24.07
Aphria (APHA) $2.563B 113.78
National Vision Holdings (EYE) United States $2.360B 46.42
HEXO (HEXO) $1.416B 0.00
Cardiovascular Systems (CSII) United States $1.374B 986.50
Phibro Animal Health (PAHC) United States $1.297B 18.65
VAREX IMAGING (VREX) United States $1.256B 24.58
AtriCure (ATRC) United States $1.094B 0.00
Lantheus Holdings (LNTH) United States $0.953B 25.76
MacroGenics (MGNX) United States $0.931B 0.00
Cerus (CERS) United States $0.852B 0.00
NanoString Technologies (NSTG) United States $0.848B 0.00
Omeros (OMER) United States $0.819B 0.00
PetIQ (PETQ) United States $0.789B 22.59
OraSure Technologies (OSUR) United States $0.719B 31.51
Meridian Bioscience (VIVO) United States $0.695B 20.71
Eagle Pharmaceuticals (EGRX) United States $0.685B 23.30
TG Therapeutics (TGTX) United States $0.652B 0.00
Evolus (EOLS) United States $0.651B 0.00
Surmodics (SRDX) United States $0.641B 93.25
LeMaitre Vascular (LMAT) United States $0.620B 29.49
Quanterix (QTRX) United States $0.546B 0.00
BioLife Solutions (BLFS) United States $0.383B 157.77
Rockwell Medical (RMTI) United States $0.354B 0.00
Vapotherm (VAPO) United States $0.333B 0.00
Insys Therapeutics (INSY) United States $0.327B 0.00
Utah Medical Products (UTMD) United States $0.312B 20.27
Owens & Minor (OMI) United States $0.283B 3.91
Bovie Medical (APYX) United States $0.262B 0.00
Cytosorbents (CTSO) United States $0.252B 0.00
Surface Oncology (SURF) United States $0.144B 0.00
Fonar (FONR) United States $0.142B 7.60
Zynex (ZYXI) United States $0.140B 15.00
Chimerix (CMRX) United States $0.103B 0.00
Chembio Diagnostics (CEMI) United States $0.101B 0.00
Female Health (VERU) United States $0.090B 0.00
United-Guardian (UG) United States $0.089B 18.54
Conatus Pharmaceuticals (CNAT) United States $0.087B 0.00
InfuSystems Holdings (INFU) United States $0.086B 0.00
CAS Medical Systems (CASM) United States $0.072B 0.00
Trinity Biotech (TRIB) Ireland $0.072B 21.43
Oramed Pharmaceuticals (ORMP) United States $0.057B 0.00
Neurotrope (NTRP) United States $0.052B 0.00
Valeritas Holdings (VLRX) United States $0.038B 0.00
ImmuCell (ICCC) United States $0.037B 0.00
Senestech (SNES) United States $0.025B 0.00
Capricor Therapeutics (CAPR) United States $0.018B 0.00
Myomo (MYO) United States $0.016B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.014B 0.00
Akers Biosciences Inc (AKER) United States $0.013B 0.00
Cellectar Biosciences (CLRB) United States $0.013B 0.00
NeuroMetrix (NURO) United States $0.008B 15.14